Alexiou Christos, Beggs David, Onyeaka Patrick, Kotidis Kostas, Ghosh Sudip, Beggs Lynda, Hopkinson David N, Duffy John P, Morgan W Ellis, Rocco Gaetano
Department of Cardiothoracic Surgery, Northern General Hospital, Sheffield, United Kingdom.
Ann Thorac Surg. 2003 Oct;76(4):1023-8. doi: 10.1016/s0003-4975(03)00883-x.
Surgically treated, stage I (T1N0 and T2N0) nonsmall cell lung cancer has a relatively favorable prognosis. Our aim was to determine whether performing a pneumonectomy in this group of patients has an impact on survival.
Four hundred eighty-five patients with stage I nonsmall cell lung cancer undergoing lung resection between 1991 and 2000 were studied. Three hundred seventy-four patients underwent a smaller resection than a pneumonectomy and 111 had a pneumonectomy.
Patients undergoing less extensive resections were older (mean age, 65 vs 63 years) (p = 0.01); these patients were also more likely to have a history of chronic obstructive airway disease (9% vs 2%) (p = 0.01) or asthma (10% vs 3%) (p = 0.04), nonsquamous cell type (56% vs 27%) (p < 0.0001), and T1 tumor stage (66% vs 17%) (p = 0.002) than patients having a pneumonectomy. Operative mortality was 2.4% versus 8% (p = 0.01). Overall 1-, 3-, and 5-year Kaplan-Meier survival rates (95% confidence interval [CI]) after less extensive resections were 85% (CI, 82% to 90%), 63% (CI, 56% to 69%), and 50% (CI, 42% to 57%), respectively, and after pneumonectomy the survival rates were 66% (CI, 53% to 73%), 47% (CI, 35% to 57%), and 44% (CI, 32% to 55%), respectively (p = 0.0006). When the Cox proportional hazards model was applied to all study patients (n = 485), pneumonectomy (p = 0.001), T2 stage (p = 0.006), older age (p = 0.03), and male gender (p = 0.03) were independent adverse predictors of survival. When the analysis was limited to the patients having T1N0 disease (n = 145), pneumonectomy (p = 0.0008), older age (p = 0.05), and nonsquamous cell type (p = 0.02) were independent adverse determinants of survival. When only the patients with T2N0 disease were analyzed (n = 340), male gender (p = 0.0005) and pneumonectomy (p = 0.01) were independent negative predictors of survival.
In this study, the patients who underwent pneumonectomy for stage T1N0 or T2N0 nonsmall cell lung cancer had a significantly poorer survival than those patients who underwent smaller lung resections.
接受手术治疗的Ⅰ期(T1N0和T2N0)非小细胞肺癌患者预后相对较好。我们的目的是确定对这组患者实施肺切除术是否会影响生存率。
对1991年至2000年间接受肺切除术的485例Ⅰ期非小细胞肺癌患者进行研究。374例患者接受了比肺切除术范围更小的切除术,111例患者接受了肺切除术。
接受范围较小切除术的患者年龄较大(平均年龄,65岁对63岁)(p = 0.01);这些患者也更有可能有慢性阻塞性气道疾病史(9%对2%)(p = 0.01)或哮喘史(10%对3%)(p = 0.04),非鳞状细胞类型(56%对27%)(p < 0.0001),以及T1肿瘤分期(66%对17%)(p = 0.002),均高于接受肺切除术的患者。手术死亡率分别为2.4%和8%(p = 0.01)。接受范围较小切除术的患者1年、3年和5年的Kaplan-Meier生存率(95%置信区间[CI])分别为85%(CI,82%至90%)、63%(CI,56%至69%)和50%(CI,42%至57%),肺切除术后的生存率分别为66%(CI,53%至73%)、47%(CI,35%至57%)和44%(CI,32%至55%)(p = 0.0006)。当将Cox比例风险模型应用于所有研究患者(n = 485)时,肺切除术(p = 0.001)、T2期(p = 0.006)、年龄较大(p = 0.03)和男性性别(p = 0.03)是生存的独立不良预测因素。当分析仅限于T1N0疾病患者(n = 145)时,肺切除术(p = 0.0008)、年龄较大(p = 0.05)和非鳞状细胞类型(p = 0.02)是生存的独立不良决定因素。当仅分析T2N0疾病患者(n = 340)时,男性性别(p = 0.0005)和肺切除术(p = 0.01)是生存的独立阴性预测因素。
在本研究中,因T1N0或T2N0非小细胞肺癌接受肺切除术的患者生存率明显低于接受范围较小肺切除术的患者。